WILMINGTON, N.C. — Paul Covington, M.D., who serves as executive vice president and chief medical officer for PPD, Inc. (Nasdaq: PPDI) will retire as of June 30. He plans to continue as a special project advisor to the company through January 2009.
Covington joined PPD in 1991 as medical director. He also worked as senior vice president of medical and regulatory affairs, and as chief safety officer prior to assuming his current post in 2002.
“Paul is one of the most talented physicians in our industry, and his leadership and unwavering commitment to excellence have played a significant role in the continued growth and success of our company,” said Fred Eshelman, chief executive officer. “I am grateful for Paul’s many contributions and tireless efforts during his 17-year tenure with PPD. On behalf of our board of directors and all of our employees, I wish him well in his retirement and immense satisfaction in his pursuit of personal interests outside of our industry.”
Although the company hopes to name a replacement by mid-2008, a consulting arrangement is likely to be established with Covington upon his full retirement. In his current role, Covington has global responsibility for regulatory affairs, pharmacovigilance, medical communications, laboratory and Phase I services for the contract research organization.
Chief Medical Officer of PPD Set to Retire
Copyright 2008 by WRAL.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
- Be careful - Chinese (guanxi) and Brazil (jeito) concepts of favors could mean trouble
Posted May. 15 10:35 a.m. - Want better climate for performance? Improve CEO communications
Posted May. 15 10:27 a.m. - Investors flip out over SilkRoad, invest $54M
Updated May. 15 10:36 a.m. - Let’s make a deal – Southern Capitol VC talks about eTix investment
Updated May. 15 5:54 p.m. - On-demand ticketing software eTix lands $1M from Southern Capitol Ventures
Updated May. 15 10:17 a.m.
- Be careful - Chinese (guanxi) and Brazil (jeito) concepts of favors could mean trouble
-
- UNC-CH transfers protein production technology to Liquidia
May. 14, 2008 - Personalized health startup Proventys lands $5.65M in financing
May. 14, 2008 - Startup Genomatica has plans to turn the chemical industry green
May. 14, 2008 - PricewaterhouseCoopers venture event rescheduled for May 29
May. 14, 2008 - Smalltown expands its scope to the Internet community at large with Webcards.com
May. 13, 2008
- UNC-CH transfers protein production technology to Liquidia
More from wrallocaltechwire.com

